Category: Eczema News
Johnson & Johnson Stock (JNJ) Update: Shares Hold Near $208 as Markets Close for the Weekend; Eczema Trial Halt, Pipeline Wins, and 2026 Outlook in Focus – ts2.tech
eczemarelief
December 28, 2025
Dermatology in 2025: Year in Review – HCPLive
eczemarelief
December 26, 2025
Sanofi Eczema Drug Linked To Lymphoma, Suit Says – Law360
eczemarelief
December 24, 2025
Year In Review: Cover Stories of 2025 – Dermatology Times
eczemarelief
December 22, 2025